WallStreetZenWallStreetZen

NASDAQ: ENGN
Engene Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Engene Therapeutics revenue was $0.00 for the trailing 12 months ending Jan 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Jan 31, 2026 was $0.0, down N/A from last quarter. For the last reported fiscal year 2025 ending Oct 31, 2025, ENGN annual revenue was $0.0, with N/A growth year-over-year.

ENGN revenue history

Current Revenue
$0.0
Current Earnings
-$122.4M
Current Profit Margin
0%

Be the first to know when ENGN announces revenue.

ENGN Revenue History By Year

ENGN Yearly RevenueENGN RevenueENGN ChangeENGN Revenue Growth
2025-10-31$0.00N/AN/A
2024-10-31$0.00N/AN/A
2023-10-31$0.00N/AN/A
2022-10-31$0.00N/AN/A
2021-10-31$0.00N/AN/A
2020-10-31$0.00N/AN/A

1 of 1

Engene Therapeutics Revenue FAQ

What was ENGN's revenue last quarter?

On Invalid Date, Engene Therapeutics (NASDAQ: ENGN) reported Q4 2025 revenue of $0.00 up N/A year over year. In the same quarter last year, Engene Therapeutics's revenue was $0.00.

What was Engene Therapeutics's revenue in 2025?

Engene Therapeutics's annual revenue for the twelve months ending Oct 31, 2025 was $0.00, a N/A decrease year over year.

How much does Engene Therapeutics make in a day?

Based on Engene Therapeutics annual revenue for the past five years, ENGN makes an average of $0.00 per day.

What was Engene Therapeutics's annual revenue growth in the past year?

As of Q2 2026, Engene Therapeutics's revenue has grown null year over year. Engene Therapeutics's revenue in the past year totaled $0.00.

How much does Engene Therapeutics make in a year?

Engene Therapeutics's revenue by year for the past five years is:
  • Engene Therapeutics's revenue for the twelve months ending Oct 31, 2025 was $0.00, a N/A decrease year over year.
  • Engene Therapeutics's annual revenue for Oct 31, 2024 was $0.00, a N/A decrease from 2023.
  • Engene Therapeutics's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
  • Engene Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
  • Engene Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.